AAV-based RNAi silencing of NADPH oxidase gp91phox attenuates cold-induced cardiovascular dysfunction

Human Gene Therapy

Volumn 23, Issue 9, 2012, Pages 1016-1026

  Wang, Xiuqing ^a,b   Skelley, Lucille ^b   Wang, Bo ^b   Mejia, Ayesha ^b   Sapozhnikov, Val ^b   Sun, Zhongjie ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SHORT HAIRPIN RNA; SUPEROXIDE;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE MONITORING; COLD EXPOSURE; CONTROLLED STUDY; GENE CONSTRUCT; GENE SILENCING; HEART; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; KIDNEY; KIDNEY HYPERTROPHY; KIDNEY INJURY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; TELEMETRY; UPREGULATION;

ANIMALS; COLD TEMPERATURE; DEPENDOVIRUS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; GENETIC THERAPY; HYPERTENSION; KIDNEY DISEASES; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SUPEROXIDES;

ADENO-ASSOCIATED VIRUS; RATTUS;

EID: 84866313579     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2012.078     Document Type: Article

References (51)

1. Baker-Blocker, A. (1982). Winter weather and cardiovascular mortality in Minneapolis-St. Paul. Am. J. Public Health 72, 261-265.
2. Brennan, P.J., Greenberg, G., Miall, W.E., and Thompson, S.G. (1982). Seasonal variation in arterial blood pressure. Br. Med. J. (Clin. Res. Ed.) 285, 919-923. (Pubitemid 12068968)
3. Crawford, V.L., McCann, M., and Stout, R.W. (2003). Changes in seasonal deaths from myocardial infarction. QJM 96, 45-52. (Pubitemid 36163810)
4. Crosswhite, P., and Sun, Z. (2010). Ribonucleic acid interference knockdown of interleukin 6 attenuates cold-induced hypertension. Hypertension 55, 1484-1491.
5. Donaldson, G.C., Robinson, D., and Allaway, S.L. (1997). An analysis of arterial disease mortality and BUPA health screening data in men, in relation to outdoor temperature. Clin. Sci. (Lond.) 92, 261-268. (Pubitemid 27129439)
6. Flotte, T.R., Trapnell, B.C., Humphries, M., et al. (2011). Phase 2 clinical trial of a recombinant adeno-associated virus vector expressing a1 antitrypsin: interim results. Hum. Gene Ther. 22, 1239-1247.
7. Fu, S., Cao, Y., Li, Y., et al. (2002). Hypertensive epidemiology in Heilongjiang Province in China. Chin. Med. J. (Engl.) 115, 498-501. (Pubitemid 34538087)
8. Gorjanc, M.L., Flanders, W.D., Vanderslice, J., et al. (1999). Effects of temperature and snowfall on mortality in Pennsylvania. Am. J. Epidemiol. 149, 1152-1160. (Pubitemid 29270329)
9. Gö rlach, A., Brandes, R.P., Nguyen, K., et al. (2000). A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87, 26-32. (Pubitemid 30456931)
10. Griendling, K.K., Sorescu, D., and Ushio-Fukai, M. (2000). NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501. (Pubitemid 30165039)
11. Grimm, D., Streetz, K.L., Jopling, C.L., et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441, 537-541. (Pubitemid 44050158)
12. Hasuwa, H., Kaseda, K., Einarsdottir, T., and Okabe, M. (2002). Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532, 227-230. (Pubitemid 35375894)
13. Hata, T., Ogihara, T., Maruyama, A., et al. (1982). The seasonal variation of blood pressure in patients with essential hypertension. Clin. Exp. Hypertens. A 4, 341-354. (Pubitemid 12105809)
14. Heymes, C., Bendall, J.K., Ratajczak, P., et al. (2003). Increased myocardial NADPH oxidase activity in human heart failure. J. Am. Coll. Cardiol. 41, 2164-2171. (Pubitemid 36724261)
15. Javesghani, D., Magder, S.A., Barreiro, E., et al. (2002). Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles. Am. J. Respir. Crit. Care Med. 165, 412-418. (Pubitemid 34118518)
16. Jones, S.A., O'Donnell, V.B., Wood, J.D., et al. (1996). Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271, H1626-H1634.
17. Krijnen, P.A., Meischl, C., Hack, C.E., et al. (2003). Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J. Clin. Pathol. 56, 194-199. (Pubitemid 36308034)
18. Levy, D., Garrison, R.J., Savage, D.D., et al. (1990). Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561-1566. (Pubitemid 20176696)
19. Li, J.M., and Shah, A.M. (2002). Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277, 19952-19960. (Pubitemid 34967517)
20. Ló pez-Barneo, J., Pardal, R., Montoro, R.J., et al. (1999). K+ and Ca2 + channel activity and cytosolic [Ca2 +[ in oxygen-sensing tissues. Respir. Physiol. 115, 215-227. (Pubitemid 29206486)
21. Michel, U., Malik, I., Ebert, S., et al. (2005). Long-term in vivo and in vitro AAV-2-mediated RNA interference in rat retinal ganglion cells and cultured primary neurons. Biochem. Biophys. Res. Commun. 326, 307-312. (Pubitemid 39593547)
22. Minami, J., Kawano, Y., Ishimitsu, T., et al. (1996). Seasonal variations in office, home and 24 h ambulatory blood pressure in patients with essential hypertension. J. Hypertens. 14, 1421-1425. (Pubitemid 27007810)
23. Mingozzi, F., and High, K.A. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 12, 341-355.
24. Newburger, P.E., Ezekowitz, R.A., Whitney, C., et al. (1988). Induction of phagocyte cytochrome b heavy chain gene expression by interferon c. Proc. Natl. Acad. Sci. U.S.A. 85, 5215-5219.
25. Nicotera, T., Thusu, K., and Dandona, P. (1993). Elevated production of active oxygen in Bloom's syndrome cell lines. Cancer Res. 53, 5104-5107. (Pubitemid 23333373)
26. Paravicini, T.M., and Touyz, R.M. (2008). NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31 Suppl 2, S170-S180.
27. Piccoli, C., Ria, R., Scrima, R., et al. (2005). Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity. J. Biol. Chem. 280, 26467-26476. (Pubitemid 41022243)
28. Reinehr, R., Becker, S., Eberle, A., et al. (2005). Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem. 280, 27179-27194. (Pubitemid 41040757)
29. Rohr, U.P., Wulf, M.A., Stahn, S., et al. (2002). Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J. Virol Methods 106, 81-88. (Pubitemid 35279652)
30. Sawyer, D.B., Siwik, D.A., Xiao, L., et al. (2002). Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 34, 379-388. (Pubitemid 37163454)
31. Schulz, E., and Munzel, T. (2008). NOX5, a new "radical"-player in human atherosclerosis? J. Am. Coll. Cardiol. 52, 1810-1812.
32. Seretakis, D., Lagiou, P., Lipworth, L., et al. (1997). Changing seasonality of mortality from coronary heart disease. JAMA 278, 1012-1014. (Pubitemid 27430199)
33. Serrano, F., Kolluri, N.S., Wientjes, F.B., et al. (2003). NADPH oxidase immunoreactivity in the mouse brain. Brain Res. 988, 193-198. (Pubitemid 37289510)
34. Sun, Z. (2010). Cardiovascular responses to cold exposure. Front. Biosci. (Elite Ed.) 2, 495-503.
35. Sun, Z., Fregly, M.J., and Cade, J.R. (1995). Effect of renal denervation on elevation of blood pressure in cold-exposed rats. Can. J. Physiol. Pharmacol. 73, 72-78.
36. Sun, Z., Cade, J.R., Fregly, M.J., and Rowland, N.E. (1997). Effect of chronic treatment with propranolol on the cardiovascular responses to chronic cold exposure. Physiol. Behav. 62, 379-384. (Pubitemid 27326910)
37. Sun, Z., Cade, R., Zhang, Z., et al. (2003). Angiotensinogen gene knockout delays and attenuates cold-induced hypertension. Hypertension 41, 322-327. (Pubitemid 36204909)
38. Sun, Z., Wang, X., Wood, C.E., and Cade, J.R. (2005). Genetic AT1A receptor deficiency attenuates cold-induced hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R433-R439. (Pubitemid 40129610)
39. Sun, Z., Bello-Roufai, M., and Wang, X. (2008). RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension. Am. J. Physiol. Heart Circ. Physiol. 294, H1880-H1887. (Pubitemid 351490617)
40. Tain, Y.L., and Baylis, C. (2006). Dissecting the causes of oxidative stress in an in vivo model of hypertension. Hypertension 48, 828-829. (Pubitemid 44610991)
41. Takemoto, M., Node, K., Nakagami, H., et al. (2001). Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J. Clin. Invest. 108, 1429-1437. (Pubitemid 33091980)
42. Tenenbaum, L., Chtarto, A., Lehtonen, E., et al. (2004). Recombinant AAV-mediated gene delivery to the central nervous system. J. Gene. Med. 6 Suppl 1, S212-S222. (Pubitemid 40228030)
43. Thorvaldsen, P., Asplund, K., Kuulasmaa, K., et al. (1995). Stroke incidence, case fatality, and mortality in the WHO MONICA project. Stroke 26, 361-367.
44. Touyz, R.M. (2004). Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248-252. (Pubitemid 39167216)
45. Touyz, R.M., and Schiffrin, E.L. (2004). Reactive oxygen species in vascular biology: implications in hypertension. Histochem. Cell Biol. 122, 339-352. (Pubitemid 39506592)
46. Touyz, R.M., Chen, X., Tabet, F., et al. (2002). Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ. Res. 90, 1205-1213. (Pubitemid 34786906)
47. Velázquez Monroy, O., Rosas Peralta, M., Lara Esqueda, A., et al. (2002). [Arterial hypertension in Mexico: results of the National Health Survey 2000]. Arch. Cardiol. Mex. 72, 71-84.
48. Verdon, F., Boudry, J.F., Chuat, M., et al. (1993). [Seasonal variations in arterial pressure in hypertensive patients]. Schweiz. Med. Wochenschr. 123, 2363-2369. (Pubitemid 24010307)
49. Wang, X., and Sun, Z. (2010). RNAi silencing of brain klotho potentiates cold-induced elevation of blood pressure via the endothelin pathway. Physiol. Genomics 41, 120-126.
50. Wang, X., Skelley, L., Cade, R., and Sun, Z. (2006). AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther. 13, 1097-1103.
51. Wang, Y., and Sun, Z. (2009). Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54, 810-817.